These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7843122)

  • 21. Protective effects of 2,3-dimercaptopropane-1-sulfonate on mercuric chloride-induced acute inhibition of enzymes from rat duodenal mucosa and kidney cortex.
    Suzuki S; Takamura S; Sugiki K; Imai M; Niwa O; Tamatani R
    Toxicology; 1994 Jan; 86(1-2):29-48. PubMed ID: 8134922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased inorganic mercury in spinal motor neurons following chelating agents.
    Ewan KB; Pamphlett R
    Neurotoxicology; 1996; 17(2):343-9. PubMed ID: 8856730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
    Gonzalez-Ramirez D; Maiorino RM; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Aposhian MM; Dart RC; Diaz Gama JH; Echeverria D
    J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of BSO, GSH, Vit-C and DMPS on the nephrotoxicity of mercury.
    Xu Z; Yang J; Yu J; Yin Z; Sun W; Li J
    Toxicol Ind Health; 2007 Aug; 23(7):403-10. PubMed ID: 18536492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
    Aposhian HV
    Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1017-25. PubMed ID: 9703487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
    Diamond GL; Klotzbach JM; Stewart JR
    J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant administration of sodium 2,3-dimercapto-1-propanesulphonate (DMPS) and diphenyl diselenide reduces effectiveness of DMPS in restoring damage induced by mercuric chloride in mice.
    Brandão R; Borges LP; Nogueira CW
    Food Chem Toxicol; 2009 Aug; 47(8):1771-8. PubMed ID: 19406194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the difference of curative effect of conventional mercury displacement treatment on mercury in brain and kidney].
    Gao ZZ; Pan YJ; Ma J; Li HL; Mei X; Song YG
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Apr; 40(4):255-259. PubMed ID: 35545590
    [No Abstract]   [Full Text] [Related]  

  • 29. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
    Muran PJ
    Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. meso-2,3-dimercaptosuccinic acid monoalkyl esters: effects on mercury levels in mice.
    Gale GR; Smith AB; Jones MM; Singh PK
    Toxicology; 1993 Jul; 81(1):49-56. PubMed ID: 8396277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the protective activity of 2,3-dimercaptopropanol and sodium 2,3-dimercaptopropane-1-sulfonate on methylmercury-induced developmental toxicity in mice.
    Gomez M; Sanchez DJ; Colomina MT; Domingo JL; Corbella J
    Arch Environ Contam Toxicol; 1994 Jan; 26(1):64-8. PubMed ID: 8110025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complexing activity and excretion of 2,3-dimercapto-1-propane sulfonate in rat kidney.
    Klotzbach JM; Diamond GL
    Am J Physiol; 1988 Jun; 254(6 Pt 2):F871-8. PubMed ID: 3381889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of acute copper(II)-induced renal lesions by sodium 2,3-dimercaptopropanesulfonate.
    Mitchell WM; Basinger MA; Jones MM
    Johns Hopkins Med J; 1982 Dec; 151(6):283-5. PubMed ID: 7176288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mobilized mercury in subjects with varying exposure to elemental mercury vapour.
    Molin M; Schütz A; Skerfving S; Sällsten G
    Int Arch Occup Environ Health; 1991; 63(3):187-92. PubMed ID: 1917069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Garza-Ocañas L; Torres-Alanís O; Piñeyro-López A
    J Toxicol Clin Toxicol; 1997; 35(6):653-5. PubMed ID: 9365436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of 2,3-dimercapto-1-propane sulfonate with the human organic anion transporter hOAT1.
    Islinger F; Gekle M; Wright SH
    J Pharmacol Exp Ther; 2001 Nov; 299(2):741-7. PubMed ID: 11602689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase of renal excretion of organo-mercury compounds like methlymercury by DMPS (2,3-Dimercapto-1-propanesulfonic acid, Dimaval).
    Drasch G; Boese-O'Reilly S; Illig S
    Clin Toxicol (Phila); 2007; 45(3):266-9. PubMed ID: 17453878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,3-Dimercaptopropane-1-sodium sulfonate for reducing retention of ingested 203Hg in suckling rats.
    Kostial K; Kargacin B; Landeka M
    Bull Environ Contam Toxicol; 1988 Aug; 41(2):185-8. PubMed ID: 3207899
    [No Abstract]   [Full Text] [Related]  

  • 39. Chelation in metal intoxication: influence of cysteine or N-acetyl cysteine on the efficacy of 2,3-dimercaptopropane-1-sulphonate in the treatment of cadmium toxicity.
    Tandon SK; Prasad S; Singh S
    J Appl Toxicol; 2002; 22(1):67-71. PubMed ID: 11807931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN
    Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.